Sunday, September 28, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Revises Price Target for Foot Locker Based on Market Conditions

Elaine Mendonca by Elaine Mendonca
March 7, 2024
in Breaking News
0
Retail Stock Bull Market
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

On March 7, 2024, Morgan Stanley analyst Alex Straton reiterated an Equal-Weight rating for Foot Locker (NYSE:FL) but revised the price target down to $26 from $28. The adjustment was made based on the analyst’s evaluation of the company’s performance and prevailing market conditions.

FL Stock Analysis: Near Bottom of 52-Week Range, Investors Cautious About Future Prospects

On March 7, 2024, FL stock closed at $24.34, near the bottom of its 52-week range and below its 200-day simple moving average. The stock saw a modest increase of $0.10, or 0.41%, from the previous close, but dropped $0.04 in after-hours trading. FL’s weak price momentum and position near the bottom of its 52-week range suggest that investors may be cautious about its prospects in the near term. Investors should monitor FL’s performance closely for any potential breakout or further declines.

FL Stock Performance Analysis: Revenue, Net Income, and EPS Decline in 2024

On March 7, 2024, FL stock performance was under scrutiny as the company released its financial results for the past year and the fourth quarter. According to data from CNN Money, FL reported a total revenue of $8.17 billion for the past year, which was a decrease of 6.75% compared to the previous year. The total revenue for the fourth quarter was $2.38 billion, which remained flat compared to the previous quarter.

In terms of net income, FL reported a net loss of $330.00 million for the past year, which was a significant decrease of 196.49% compared to the previous year. However, the net loss for the fourth quarter was $389.00 million, which showed no change compared to the previous quarter.

Earnings per share (EPS) for FL were also on a downward trend, with a reported EPS of -$3.50 for the past year, a decrease of 197.82% compared to the previous year. The EPS for the fourth quarter was -$4.12, which showed no change compared to the previous quarter.

Overall, FL stock performance on March 7, 2024, was impacted by the decrease in total revenue, net income, and EPS compared to the previous year. Investors may be concerned about the company’s financial health and future prospects based on these results. It will be important for FL to address these challenges and implement strategies to improve its financial performance in the coming quarters.

Tags: FL
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Food Producers Stock Exchange

Analysts Bullish on BellRing Brands Strong Buy Recommendations and Positive Outlook

Unlocking Value: The Economic Potential of Iron-Titanium-Vanadium Projects

Westlake Corporation CFO Sells Shares Amid Financial Challenges

Analyst Ratings Show Bullish Sentiments for Boston Scientific

Recommended

Burlington Stores Stock

Burlington Stores Delivers Strong Quarter Amid Cautious Forecast

2 weeks ago
Finance analyst

Financial Expert Eric Beaumont Upholds EqualWeight Rating for Atmos Energy with Increased Price Target

2 years ago

NeoGames SA Partners with Georgia Lottery Corporation to Introduce Premium eInstants

2 years ago
Biotechnology Markets and money

Revolutionizing Rare Disease Therapeutics A Partnership Between Invitae and BridgeBio Pharma

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Defense Contractor Mercury Soars on Major Avionics Contract

Can Playstudios Reverse Its Downward Trajectory?

Micron’s AI-Driven Surge: Record Earnings and Bullish Outlook

Marvell Technology Unveils Massive $5 Billion Share Repurchase Initiative

Shareholders Face Complete Wipeout in Wolfspeed Restructuring

Wabash National’s Strategic Gamble Amid Industry Downturn

Trending

Uranium Energy Stock
Stocks

Uranium Energy’s Mixed Signals: Production Milestone Overshadowed by Earnings Miss

by Dieter Jaworski
September 28, 2025
0

Uranium Energy Corp. finds itself at a critical juncture following the release of its fiscal 2025 results....

Eli Lilly Stock

Eli Lilly Strengthens Oncology Pipeline with New Breast Cancer Treatment Approval

September 28, 2025
Ocugen Stock

Ocugen Stock: Conflicting Signals Create Investor Uncertainty

September 28, 2025
Mercury Stock

Defense Contractor Mercury Soars on Major Avionics Contract

September 28, 2025
Playstudios Stock

Can Playstudios Reverse Its Downward Trajectory?

September 28, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Uranium Energy’s Mixed Signals: Production Milestone Overshadowed by Earnings Miss
  • Eli Lilly Strengthens Oncology Pipeline with New Breast Cancer Treatment Approval
  • Ocugen Stock: Conflicting Signals Create Investor Uncertainty

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com